May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

VISTA, Calif.—Mar 2, 2020—Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a significant development for anatomical pathology laboratories by bringing together its Aperio AT2 DX...

Leica Biosystems is proud to present: Validation of A Digital Pathology System for Primary Diagnosis in Surgical Pathology with Dr. Jinsong Qiu, PhD Wednesday, March 4th, 2020 West Exhibit Hall A – Room #2 12:00 pm – 1:00 pm The...

First medium-capacity autoloader expands the capabilities of the SL5 and L5 systems February 27, 2020 (Carlsbad, CA) - Mikroscan Technologies, innovators and manufacturers of live robotic microscopy and whole-slide imaging (WSI) systems,...

3DHISTECH is proud to announce that it has, for the second time, won the GHP Technology Award. Founded by Global Health & Pharma, a global information sharing platform and a multi-disciplinary professional community, the GHP...

OR

platinum partners

gold partners

Silver Partners

Media Partners